|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Monitoring and Other Related Services | |||||
| Product Sales and Other | |||||
| Total revenues | |||||
| Cost of revenue: | |||||
| Monitoring, products and other related services | |||||
| Depreciation and amortization included in cost of revenue | |||||
| Total cost of revenue | |||||
| Gross profit | |||||
| Operating expense: | |||||
| General & administrative | |||||
| Selling & marketing | |||||
| Research & development | |||||
| Depreciation & amortization | |||||
| Impairment on assets held for sale | |||||
| Impairment on assets held for sale/loss on sale of subsidiary | |||||
| Total operating expense | |||||
| Operating income (loss) | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Currency exchange rate gain (loss) | |||||
| Other income (expense), net | |||||
| Total other income (expense) | |||||
| Income (loss) before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net income (loss) attributable to common stockholders | |||||
| Release of cumulative translation adjustment for sale of subsidiary | |||||
| Equity adjustment for sale of subsidiary | |||||
| Foreign currency translation adjustments | |||||
| Comprehensive income (loss) | |||||
| Net income (loss) per share – basic: | |||||
| Net income (loss) per common share (in dollars per share) | |||||
| Weighted average common shares outstanding (in shares) | |||||
| Net income (loss) per share – diluted: | |||||
| Net income (loss) per common share (in dollars per share) | |||||
| Weighted average common shares outstanding (in shares) |
Loading...